Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice
Fred H. Menko, Jacqueline A. ter Stege, Lizet E. van der Kolk, et al.
Familial Cancer (2018) Vol. 18, Iss. 1, pp. 127-135
Closed Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Young-onset colorectal cancer
Manon C.W. Spaander, Ann G. Zauber, Sapna Syngal, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 134
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis
Melissa K. Frey, Muhammad Danyal Ahsan, Hannah Bergeron, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 35, pp. 4129-4143
Open Access | Times Cited: 76
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening
Kenneth Offit, Kaitlyn Tkachuk, Zsofia K. Stadler, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 13, pp. 1398-1408
Open Access | Times Cited: 84
The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care—A Systematic Review
Kyra Bokkers, Michiel Vlaming, Ellen G. Engelhardt, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1059-1059
Open Access | Times Cited: 51
Public perspectives on healthcare professional-directed communication of hereditary genetic risks: a mixed-method systematic review
Lea Godino, Daniela Turchetti, Valentina Gentili, et al.
European Journal of Human Genetics (2025)
Closed Access | Times Cited: 1
Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis
Vasiliki Baroutsou, Meghan Underhill‐Blazey, Christian Appenzeller‐Herzog, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 925-925
Open Access | Times Cited: 46
Direct notification by health professionals of relatives at-risk of genetic conditions (with patient consent): views of the Australian public
Jane Tiller, Ami Stott, Keri Finlay, et al.
European Journal of Human Genetics (2023) Vol. 32, Iss. 1, pp. 98-108
Open Access | Times Cited: 16
Epithelial ovarian cancer risk: A review of the current genetic landscape
Nicola Flaum, Emma J. Crosbie, Richard J. Edmondson, et al.
Clinical Genetics (2019) Vol. 97, Iss. 1, pp. 54-63
Open Access | Times Cited: 50
Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature
Alessandro De Luca, Federico Frusone, Massimo Vergine, et al.
In Vivo (2019) Vol. 33, Iss. 4, pp. 1313-1324
Open Access | Times Cited: 49
Cascade Genetic Testing for Hereditary Cancer Risk: An Underutilized Tool for Cancer Prevention
Kristen Whitaker, Elias Obeid, Mary B. Daly, et al.
JCO Precision Oncology (2021), Iss. 5, pp. 1387-1396
Open Access | Times Cited: 39
Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluation
Fred H. Menko, Sophie L. van der Velden, Diana N. Griffioen, et al.
Journal of Genetic Counseling (2023) Vol. 33, Iss. 3, pp. 615-622
Closed Access | Times Cited: 14
A Focused Clinical Review of Lynch Syndrome
Demetra Georgiou, Laura Monje‐Garcia, Tracie Miles, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 67-85
Open Access | Times Cited: 13
Assessing relatives’ readiness for hereditary cancer cascade genetic testing
Erica M. Bednar, Charlotte C. Sun, Sheryl McCurdy, et al.
Genetics in Medicine (2019) Vol. 22, Iss. 4, pp. 719-726
Open Access | Times Cited: 36
Patient and Family Preferences on Health System-Led Direct Contact for Cascade Screening
Nora B. Henrikson, Paula R. Blasi, Marlaine Figueroa Gray, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 6, pp. 538-538
Open Access | Times Cited: 28
The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband–Provider and Proband–Family Communication in Hereditary Breast and Ovarian Cancer
Carla Pedrazzani, Mónica Aceti, Reka Schweighoffer, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1249-1249
Open Access | Times Cited: 19
National Experiences from 30 Years of Provider-Mediated Cascade Testing in Lynch Syndrome Families—The Danish Model
Lars Joachim Lindberg, Karin Wadt, Christina Therkildsen, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1577-1577
Open Access | Times Cited: 4
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework
Hadley Stevens Smith, Dean A. Regier, Ilias Goranitis, et al.
Applied Health Economics and Health Policy (2025)
Closed Access
Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants
Liis Leitsalu, Marili Palover, Timo Tõnis Sikka, et al.
European Journal of Human Genetics (2020) Vol. 29, Iss. 3, pp. 471-481
Open Access | Times Cited: 32
The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives
Tara Schmidlen, Sara L. Bristow, Kathryn E. Hatchell, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 17
Clinician perspectives on policy approaches to genetic risk disclosure in families
Amicia Phillips, Danya F. Vears, Ine Van Hoyweghen, et al.
Familial Cancer (2024) Vol. 23, Iss. 2, pp. 177-186
Open Access | Times Cited: 3
How to inform at‐risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population
Lieke M. van den Heuvel, Daphne Stemkens, Wendy A.G. van Zelst–Stams, et al.
Journal of Genetic Counseling (2019) Vol. 29, Iss. 5, pp. 786-799
Open Access | Times Cited: 28
The uptake of predictive DNA testing in 40 families with a pathogenic BRCA1/BRCA2 variant. An evaluation of the proband-mediated procedure
Fred H. Menko, Kiki N. Jeanson, Eveline M. A. Bleiker, et al.
European Journal of Human Genetics (2020) Vol. 28, Iss. 8, pp. 1020-1027
Open Access | Times Cited: 26
What guidance does HIPAA offer to providers considering familial risk notification and cascade genetic testing?
Nora B. Henrikson, Jennifer K. Wagner, Heather Hampel, et al.
Journal of Law and the Biosciences (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 25
Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden
Andréas Andersson, Carolina Hawranek, Anna Öfverholm, et al.
Hereditary Cancer in Clinical Practice (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 24
A systematic literature review of disclosure practices and reported outcomes for medically actionable genomic secondary findings
Julie C. Sapp, Flavia M. Facio, Diane Cooper, et al.
Genetics in Medicine (2021) Vol. 23, Iss. 12, pp. 2260-2269
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top